• Profile
Close

Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with the prognostic outcome of patients

American Journal of Otolaryngology - Head and Neck Medicine and Surgery Apr 06, 2019

Karamagkiolas S, et al. - Researchers estimated tissue specimens of 69 candidates with laryngeal squamous cell carcinoma (LSCC) to study the possible combined prognostic significance of NOTCH1, Vimentin (VIM), and Metastasis-associated 1 (MTA1) protein in LSCC using immunohistochemistry. In Kaplan-Meier survival analysis, they noted no importance of NOTCH1 expression status as a prognosticator in LSCC. But they found an important prognostic potential of both VIM and MTA1, independent of TNM staging as well as the histological grade of the tumor. In fact, in contrast to MTA1, the positive expression of which predicts higher disease-free survival (DFS) and overall survival (OS) rates in LSCC, positive VIM expression has been shown to predict patients' relapse and poor outcome regarding OS of subjects.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay